Washington—Draft guidelines from the American Gastroenterological Association recommend that only laxatives and peripherally acting mu-opioid receptor antagonists be used for the pharmaceutical treatment of opioid-induced constipation (OIC).
The document, presented during the 2018 Digestive Disease Week, advises
OCTOBER 4, 2018